Business context and reporting period
Microchip Technology Incorporated develops, manufactures and sells embedded control solutions, including mixed-signal microcontrollers, analog products, FPGAs, memory, timing, connectivity and related technology licensing. This summary is based on the Form 10-K for the fiscal year ended March 31, 2023; the supplied metadata refers to “2022 Q4,” but the filing is an annual report rather than a quarterly filing.
Microchip reports two segments: semiconductor products and technology licensing. Approximately 78% of fiscal 2023 sales were to foreign customers, with China representing approximately 21% and Taiwan approximately 14% of consolidated sales. Distributors generated 47% of net sales, compared with 48% in fiscal 2022.
Key financial metrics
| Metric | Fiscal 2023 | Fiscal 2022 | Change |
|---|---|---|---|
| Net sales | $8,438.7 million | $6,820.9 million | 23.7% increase |
| Gross profit | $5,697.9 million | $4,449.6 million | 28.1% increase |
| Gross margin | 67.5% | 65.2% | 230 basis-point increase |
| Operating income | $3,116.0 million | $1,849.6 million | 68.5% increase |
| Operating margin | 36.9% | 27.1% | 980 basis-point increase |
| Net income | $2,237.7 million | $1,285.5 million | 74.1% increase |
| Diluted earnings per share | $4.02 | $2.27 | Increase |
| Cash flow from operations | $3,621.0 million | $2,842.7 million | 27.4% increase |
| Capital expenditures | $486.2 million | $370.1 million | 31.4% increase |
| Cash and cash equivalents | $234.0 million | $317.4 million | Decrease |
| Gross debt principal | $6,466.6 million | $7,837.2 million | Decrease |
Fiscal 2023 sales increased across all product lines: mixed-signal microcontrollers rose 24.7% to $4,755.7 million, analog rose 22.6% to $2,376.9 million, and other products and services rose 22.4% to $1,306.1 million. Technology licensing revenue was $161.0 million, compared with $122.0 million.
Gross profit benefited from product mix, pricing and higher average gross profit per unit. Inventory reserve charges of $89.0 million reduced fiscal 2023 gross profit. Inventory increased to $1,324.9 million from $854.4 million, or 169 days versus 125 days, reflecting supply-chain purchasing, strategic last-time buys and customer order push-outs.
Interest expense declined to $203.9 million from $257.0 million, while loss on debt settlement declined to $8.3 million from $113.4 million. Income tax expense increased to $672.0 million from $197.0 million, partly due to the capitalization and amortization of research and development costs required under the Tax Cuts and Jobs Act.
Financing cash uses included $1,470 million of debt principal repayments, $695.3 million of dividends and $945.8 million of share repurchases. The company had $2.63 billion remaining under its $4.00 billion repurchase authorization at March 31, 2023.
Material changes versus the prior comparable period
- Revenue, operating income and net income increased substantially, supported by strong demand, price increases and favorable product mix.
- Gross and operating margins expanded despite $89.0 million of inventory reserve charges and higher research and development and selling expenses.
- Debt declined, with outstanding borrowings under the revolving credit facility falling to $100.0 million from $1.40 billion.
- Inventory and accounts receivable increased materially, tying up working capital. Inventory rose approximately 55%, and accounts receivable increased to $1,305.3 million from $1,072.6 million.
- The company adopted ASU 2020-06 for convertible debt, increasing convertible debt by $105.8 million, reducing additional paid-in capital by $128.3 million and increasing opening retained earnings by $46.5 million.
- Amortization of acquired intangible assets declined to $669.9 million from $862.5 million. Net intangible assets were $3,369.0 million and goodwill was $6,673.6 million at March 31, 2023.
- Customers increasingly requested order push-outs or cancellations in the March 2023 quarter as economic conditions slowed. The company paused most factory expansion activity and reduced planned fiscal 2024 capital investment.
Guidance, outlook, commentary and risks
- Management expects inventory to decline, with projected inventory days of 159 to 164 days at June 30, 2023.
- The company currently expects to invest $300 million to $400 million in equipment and facilities over the next 12 months, versus fiscal 2023 capital expenditures of $486.2 million.
- Microchip announced a planned $880 million, multi-year expansion of silicon carbide and silicon production capacity at Fab 5. It also continued an $800 million expansion plan at Fab 4.
- The company expects existing liquidity, operating cash flow and revolving-credit borrowings to fund anticipated requirements for at least the next 12 months.
- Debt maturities are significant: expected fiscal 2024 maturities total $3.40 billion, including the $1.00 billion 4.333% notes due June 1, 2023 and the $1.00 billion 2.670% notes due September 1, 2023. Management intends to refinance the 4.333% notes using the revolving facility.
- The company has approximately $4.18 billion of remaining performance obligations under long-term supply agreements, with approximately 15% expected to be recognized as sales over the next 12 months. Timing is uncertain and deposits may need to be refunded if customers meet purchase commitments or Microchip fails to assure supply.
- Key risks include semiconductor demand volatility, customer inventory corrections, pricing pressure, excess or obsolete inventory, reliance on external wafer foundries and assembly/test contractors, geopolitical and trade restrictions, foreign operations, distributor concentration, cybersecurity incidents, intellectual-property litigation and execution risk on capacity expansions.
- A proposed Malaysian tax adjustment for fiscal 2020 could result in taxes of up to $420.0 million, excluding interest and penalties, if upheld. The company disputes the assessment. Gross unrecognized tax benefits were $848.0 million at March 31, 2023.
- Legal matters include proposed settlement of shareholder derivative litigation involving a $4.0 million insurance payment to the company and up to $1.8 million of plaintiff attorney fees payable by the company, subject to final court approval. Potential legal liabilities that are possible but not probable were estimated at approximately $150.0 million above accrued amounts.
- The company reported no goodwill impairment in fiscal 2023, but future impairment remains a risk given the $6.67 billion goodwill balance and economic uncertainty.
Most important facts for investors to verify
- Whether customer order push-outs and elevated inventory lead to lower revenue, margin pressure or additional inventory write-downs.
- How the company refinances or repays the approximately $3.40 billion of fiscal 2024 debt maturities and the resulting interest expense.
- Actual fiscal 2024 capital expenditures and the pace and expected returns of the Fab 4 and Fab 5 expansion projects.
- Cash flow effects of long-term supply agreement deposits, including future refunds and recognition of deferred revenue.
- Developments in the Malaysian tax assessment, IRS transfer-pricing dispute and $848.0 million of unrecognized tax benefits.
- Exposure to China, Taiwan, export controls, tariffs and third-party manufacturing capacity.
- Progress on reducing inventory days from 169 at March 31, 2023 and the sustainability of the 67.5% gross margin.